Supplemental Financial Data

3 Months Ended

Mar. 31, 2025

Supplemental Financial Data [Abstract]

Supplemental Financial Data

3. Supplemental Financial Data

Inventories

Our inventories consisted of the following (in thousands):

	March 31, 2025		December 31, 2024
Raw materials	$	640	$	5,557
Work in process		8,744		6,679
Finished goods		2,118		276
Total inventories	$	11,502	$	12,512

Accrued Liabilities

Our accrued liabilities consisted of the following (in thousands):

	March 31, 2025		December 31, 2024
Clinical expenses	$	67,614	$	77,436
In-licensing expenses		7,374		7,951
Commercial expenses		7,257		3,589
Other miscellaneous expenses		20,490		19,462
Total accrued liabilities	$	102,735	$	108,438